FitLife Brands, Inc. — Form 10-Q Summary
Business Context and Reporting Period
FitLife Brands, Inc. is a provider of nutritional supplements and wellness products sold through GNC, specialty and mass retailers, online channels, and Amazon. The filing covers the quarter and six months ended June 30, 2023; amounts are in thousands except per-share data.
The company completed its acquisition of Mimi’s Rock Corp. (“MRC”) on February 28, 2023. MRC markets Dr. Tobias, All Natural Advice, and Maritime Naturals products, primarily through Amazon.
Key Financial Metrics
| Metric | Q2 2023 | Q2 2022 | Six Months 2023 | Six Months 2022 |
|---|---|---|---|---|
| Revenue | $14,760 | $7,824 | $25,498 | $15,118 |
| Gross profit | $5,965 | $3,490 | $10,373 | $6,601 |
| Gross margin | 40.4% | 44.6% | 40.7% | 43.7% |
| Operating income | $2,584 | $1,825 | $3,258 | $3,421 |
| Net income | $1,964 | $1,446 | $2,120 | $2,736 |
| Diluted EPS | $0.40 | $0.29 | $0.43 | $0.55 |
| Net cash from operations | Not separately disclosed | Not separately disclosed | $1,794 | $2,378 |
Q2 operating margin was approximately 17.5%, compared with 23.3% in the prior-year quarter. Six-month operating margin was approximately 12.8%, compared with 22.6%. Q2 net margin was approximately 13.3%, compared with 18.5%; six-month net margin was approximately 8.3%, compared with 18.1%.
Management reported non-GAAP EBITDA of $2,607 for Q2 and $3,300 for the six-month period. Adjusted EBITDA was $2,966 and $5,296, respectively, after excluding items including stock compensation, M&A costs, inventory step-up amortization, and other non-recurring costs.
Liquidity, Cash Flow, and Debt
- Cash and cash equivalents were $8,882 at June 30, 2023, plus $951 of restricted cash, for total cash and restricted cash of $9,833.
- Working capital was approximately $12,630, down from $18,933 at December 31, 2022.
- Operating cash flow was $1,794 for the first six months, compared with $2,378 in the prior-year period.
- Investing cash outflow was $17,153, including $17,099 paid for the MRC acquisition.
- Financing cash inflow was $11,875, reflecting $12,500 of term-loan borrowings less $625 of principal repayment.
- Term-loan debt was $11,875 at June 30, 2023, and the $3,500 revolving credit facility had no outstanding balance.
- The term loan bears interest at one-month SOFR plus 2.75% and matures February 28, 2028. The company was in compliance with its debt covenants at quarter-end.
- Management expects operating cash flow, existing cash, and available revolver capacity to support liquidity for the next twelve months, but states that no assurance can be given.
Material Changes Versus the Prior Comparable Period
- Q2 revenue increased 89%, primarily from MRC. Legacy FitLife revenue was approximately $7.1 million, down 9%, with wholesale revenue down 17% and online revenue up 15%.
- Six-month revenue increased 69% to $25,498. Legacy FitLife revenue was approximately $15.2 million, up 1%, with online revenue up 21% and wholesale revenue down 7%.
- Online revenue increased to approximately 67% of Q2 revenue and 59% of six-month revenue, compared with 27% in both prior-year periods. Wholesale revenue represented the balance.
- Gross margin declined because of inflationary product costs, higher online distribution costs, and MRC inventory fair-value step-up amortization. Excluding step-up amortization, Q2 and six-month gross margins would each have been approximately 41.9%.
- SG&A increased 124% in Q2 and 90% for the six-month period, primarily due to MRC-related operating expenses.
- Six-month M&A-related costs increased to $1,487 from $208. Q2 M&A costs were $115, compared with $203.
- Six-month net income declined 23%, primarily due to $1,487 of acquisition costs, $323 of inventory step-up amortization, and a $112 loss on a foreign-currency forward contract.
Outlook, Commentary, Risks, and Unusual Items
- No formal revenue or earnings guidance is provided. Management expects online revenue to continue increasing relative to prior periods and believes e-commerce investment may support near-term incremental sales and longer-term benefits.
- MRC purchase-price allocation remains provisional. At June 30, the company reported $7,957 of provisional intangible assets and $13,559 of provisional goodwill; future measurement-period adjustments may affect reported assets, liabilities, goodwill, and earnings.
- Inflation has affected product procurement costs. The company has generally offset much of the impact through price increases, but further inflation could pressure margins if price increases cannot be sustained.
- The business has customer and channel concentration: GNC represented 29% of Q2 revenue and 37% of six-month revenue, versus 69% in each prior-year comparable period.
- Interest-rate exposure increased following the SOFR-based term loan. Foreign-currency exposure also increased through MRC’s Canadian operations.
- Goodwill impairment indicators were not identified at June 30, 2023, but goodwill valuation depends partly on the company’s stock price and other estimates.
- Management stated that no material litigation or material changes to the previously disclosed Form 10-K risk factors existed.
- Management concluded that disclosure controls and procedures were effective as of June 30, 2023 after implementing a remediation plan for previously identified material weaknesses.
- The board authorized an additional $5,000 share-repurchase capacity through March 2025; no shares were repurchased during the quarter or six-month period.
Important Facts for Investors to Verify
- Whether MRC integration produces sustainable revenue and earnings growth after removing acquisition-related and inventory step-up effects.
- The final MRC purchase-price allocation and any resulting adjustments to provisional goodwill, intangible assets, deferred taxes, or future amortization.
- Legacy FitLife revenue trends, particularly declining wholesale sales and the profitability of the expanding online channel.
- Gross-margin durability amid inflation, distribution costs, and pricing actions.
- Compliance with the term-loan covenants and the company’s ability to service SOFR-linked debt from operating cash flow.
- Whether cash generation is sufficient to fund working capital, scheduled debt amortization, and potential acquisition or repurchase activity without additional financing.
- The effectiveness of the newly remediated internal controls over a sustained period.